Omega Fund Management, LLC
Boston MA · SEC CIK 0001637359
$1.86亿2026Q2 申报市值
10持仓数
100.0%前十大占比 · 第一大 29.1%
1 / 1新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q2 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | $5,409.96万 | 29.14% | 1,822,150 | -570,000 | -23.8% | -$1,692.33万 | 减仓 |
| NUVB | Nuvation Bio Inc. | $4,590.06万 | 24.72% | 8,081,089 | 0 | 0.0% | — | 不变 |
| KMTS | Kestra Med Technologies Ltd | $2,600.35万 | 14.00% | 1,022,149 | 0 | 0.0% | — | 不变 |
| BBOT | BridgeBio Oncology Therapeutics Inc. | $2,506.72万 | 13.50% | 3,289,661 | 0 | 0.0% | — | 不变 |
| BBNX | Beta Bionics Inc. | $2,062.46万 | 11.11% | 1,316,183 | 0 | 0.0% | — | 不变 |
| ALMS | Alumis Inc. | $678.89万 | 3.66% | 241,255 | 0 | 0.0% | — | 不变 |
| SANA | Sana Biotechnology, Inc. | $294.47万 | 1.59% | 843,750 | 0 | 0.0% | — | 不变 |
| — | ImageneBio, Inc. | $268.66万 | 1.45% | 455,361 | 0 | 0.0% | — | 不变 |
| — | enGene Holdings Inc. | $151.61万 | 0.82% | 876,357 | 0 | 0.0% | — | 不变 |
| ODTX | Odyssey Therapeutics Inc. | $5.41万 | 0.03% | 2,893 | 2,893 | — | $5.41万 | 新建仓 |
| REPL | Replimune Group | $0 | 0.00% | 0 | -248,672 | -100.0% | -$190.98万 | 清仓 |